, Jan. 29, 2015 /PRNewswire-USNewswire/ -- According the the NIH, oncology research funding from the National Cancer Institute (NCI) has remained flat for over a decade. To bridge the gap, the Myeloma Crowd Research Initiative (MCRI) has formed to select and fund promising research aimed at finding a cure for multiple myeloma, the second most common blood cancer. MCRI will use crowd funding via the Internet and social media to raise funds for this effort. The MCRI board features myeloma specialists, researchers, doctors, and knowledgeable patient advocates who, together, will review submissions that pose the potential for a cure and select individual projects to fund. Today, MCRI announced that it has added four new board members:
These new members join those currently on the MCRI board: Dr. Noopur Raje, MD, PhD, (Massachusetts General Cancer Center), Dr. Rafael Fonseca, MD (Mayo Clinic Scottsdale), Dr. Ola Landgren, MD, PhD (MSKCC), Dr. Guido Tricot, MD, PhD ( University of Iowa), and Dr. Irene Ghobrial, MD, PhD (Dana Farber Cancer Institute), and patient advocates Pat Killingsworth, Gary Petersen, Jack Aiello and Jenny Ahlstrom. "Many promising research proposals never make it to the labs due to lack of funding," said Chmielewski. "Patients and researchers bring different perspectives to treating disease and can now work in collaboration to select promising, innovative ideas." Contact: Jenny Ahlstrom Myeloma Crowd 801.949.1034 jenny@crowdcare.org
, Jan. 29, 2015 /PRNewswire-USNewswire/ -- According the the NIH, oncology research funding from the National Cancer Institute (NCI) has remained flat for over a decade. To bridge the gap, the Myeloma Crowd Research Initiative (MCRI) has formed to select and fund promising research aimed at finding a cure for multiple myeloma, the second most common blood cancer. MCRI will use crowd funding via the Internet and social media to raise funds for this effort. The MCRI board features myeloma specialists, researchers, doctors, and knowledgeable patient advocates who, together, will review submissions that pose the potential for a cure and select individual projects to fund. Today, MCRI announced that it has added four new board members:
These new members join those currently on the MCRI board: Dr. Noopur Raje, MD, PhD, (Massachusetts General Cancer Center), Dr. Rafael Fonseca, MD (Mayo Clinic Scottsdale), Dr. Ola Landgren, MD, PhD (MSKCC), Dr. Guido Tricot, MD, PhD ( University of Iowa), and Dr. Irene Ghobrial, MD, PhD (Dana Farber Cancer Institute), and patient advocates Pat Killingsworth, Gary Petersen, Jack Aiello and Jenny Ahlstrom. "Many promising research proposals never make it to the labs due to lack of funding," said Chmielewski. "Patients and researchers bring different perspectives to treating disease and can now work in collaboration to select promising, innovative ideas." Contact: Jenny Ahlstrom Myeloma Crowd 801.949.1034 jenny@crowdcare.org
about the author
Lizzy Smith
Lizzy Smith was diagnosed with myeloma in 2012 at age 44. Within days, she left her job, ended her marriage, moved, and entered treatment. "To the extent I'm able, I want to prove that despite life's biggest challenges, it is possible to survive and come out stronger than ever," she says.
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.